Latest filing published 27 Feb 2024 for Arvinas, INC., €74k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Sean A. Cassidy is a declared insider at 2 companies (finance chief); the most frequent names are Arvinas, Inc. and Curagen Corp. Over a trading history stretching from 1 October 2009 to 23 February 2024, the count stands at 46 filings.
Both buying and selling appear: 1 purchase worth €22k, against 26 sales worth €8.0M. On balance, insiders were net sellers of €8.0M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant and 15 option exercises. 2024 to date brings no purchases and 1 sale.
On 27 February 2024 came the latest disclosure, an open-market sale for €74k in Arvinas, Inc. The latest purchase dates back some time: it was published 2,943 days ago, on 3 October 2018. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations